Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
levonorgestrel-releasing intrauterine system (LCS16)
- Development stage
- Unknown
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Intrauterine
01
Overview
Levonorgestrel-releasing intrauterine system (LCS16) is a long-acting reversible contraceptive device designed for intrauterine placement, releasing levonorgestrel at an initial in vitro rate of approximately 16 micrograms per day. It is primarily indicated for contraception in women of reproductive age and provides up to five years of pregnancy prevention. The mechanism of action involves local release of the progestin hormone levonorgestrel, which thickens cervical mucus to inhibit sperm passage, suppresses endometrial growth to prevent implantation, and may partially inhibit ovulation[2][6][7]. LCS16 is marketed under the brand name Kyleena and was developed by Bayer.
- Brand names
- Kyleena
- Other names
- levonorgestrel 19.5 mg intrauterine delivery systemlevonorgestrel19.5 mg intrauterine delivery systemlevonorgestrel-19.5 mg intrauterine delivery systemLNG-IUS 19.5 mgLNG-IUS19.5 mgLNG-IUS-19.5 mg
02
Targets
PR (Progesterone receptor)
Beyond the preview
Go deeper on levonorgestrel-releasing intrauterine system (LCS16).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on levonorgestrel-releasing intrauterine system (LCS16).